target audience: TECH BUYER Publication date: Nov 2023 - Document type: IDC Perspective - Doc Document number: # AP51312323
GenAI in Action: TCG Lifesciences Envisions to Drive Productivity of R&D Team Through GenAI-Led Knowledge Management
Content
List of Tables
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Perspective examines the adoption level of generative AI (GenAI) technologies in TCG Lifesciences Pvt. Limited (TCGLS). The document's objective is to provide enterprises with practical insights and guidance relating to GenAI solutions adoption and ways of leveraging it to deliver to a wide range of use cases across the enterprise.
"Leveraging AI for productivity gains is only the tip of the iceberg. Enterprises' ability to build differentiation in the market and create new business models using AI will be a game-changer. Leaders must adopt different approaches to maximize AI potential in their organizations, specifically GenAI. AI and GenAI will disrupt every industry in the near future through a multitude of use cases, ranging from intelligent knowledge search to innovative customer engagement," says Deepika Giri, associate VP, Data and AI, IDC Asia/Pacific.